Femasys Inc. (FEMY)
FEMY Stock Price Chart
Explore Femasys Inc. interactive price chart. Choose custom timeframes to analyze FEMY price movements and trends.
FEMY Company Profile
Discover essential business fundamentals and corporate details for Femasys Inc. (FEMY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
18 Jun 2021
Employees
69.00
Website
https://www.femasys.comCEO
Kathy Lee-Sepsick
Description
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. Additionally, the company markets its FemVue saline-air device across various international regions, including the U.S., Europe, Canada, and Japan. Its infertility-related products are supplied to obstetrician-gynecologists, other allied healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. The company also offers a range of non-surgical product technologies.
FEMY Financial Timeline
Browse a chronological timeline of Femasys Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$1.27, while revenue estimate is $730.67k.
Stock split effective on 8 Jun 2026
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 May 2026
EPS came in at $0.10 surpassing the estimated -$1.33 by +107.35%, while revenue for the quarter reached $424.89k , missing expectations by -44.60%.
Earnings released on 31 Mar 2026
EPS came in at -$0.20 surpassing the estimated -$1.67 by +88.00%, while revenue for the quarter reached $814.31k , missing expectations by -23.18%.
Earnings released on 14 Nov 2025
EPS came in at -$0.10 surpassing the estimated -$0.12 by +13.04%, while revenue for the quarter reached $729.39k , missing expectations by -45.97%.
Earnings released on 8 Aug 2025
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $409.27k , missing expectations by -60.06%.
Earnings released on 8 May 2025
EPS came in at -$0.23 falling short of the estimated -$0.17 by -35.29%, while revenue for the quarter reached $341.26k , missing expectations by -70.13%.
Earnings released on 27 Mar 2025
EPS came in at -$0.23 falling short of the estimated -$0.19 by -24.32%, while revenue for the quarter reached $582.11k , missing expectations by -65.01%.
Earnings released on 12 Nov 2024
EPS came in at -$0.24 falling short of the estimated -$0.20 by -20.00%, while revenue for the quarter reached $554.91k , missing expectations by -18.05%.
Earnings released on 8 Aug 2024
EPS came in at -$0.21 falling short of the estimated -$0.18 by -16.67%, while revenue for the quarter reached $221.48k , missing expectations by -71.72%.
Earnings released on 9 May 2024
EPS came in at -$0.17 surpassing the estimated -$0.22 by +22.73%, while revenue for the quarter reached $271.14k , missing expectations by -65.08%.
Earnings released on 28 Mar 2024
EPS came in at -$0.19 matching the estimated -$0.19, while revenue for the quarter reached $221.97k , missing expectations by -6.24%.
Earnings released on 14 Nov 2023
EPS came in at -$0.26 falling short of the estimated -$0.25 by -4.00%, while revenue for the quarter reached $244.36k , missing expectations by -13.04%.
Earnings released on 10 Aug 2023
EPS came in at -$0.22 falling short of the estimated -$0.19 by -14.29%, while revenue for the quarter reached $320.51k , missing expectations by -8.23%.
Earnings released on 11 May 2023
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $293.98k , missing expectations by -13.53%.
Earnings released on 30 Mar 2023
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%, while revenue for the quarter reached $235.22k , missing expectations by -36.51%.
Earnings released on 10 Nov 2022
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $347.46k , missing expectations by -1.15%.
Earnings released on 10 Aug 2022
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $303.11k , missing expectations by -1.69%.
Earnings released on 11 May 2022
EPS came in at -$0.24 falling short of the estimated -$0.21 by -14.29%, while revenue for the quarter reached $321.41k , beating expectations by +7.14%.
Earnings released on 24 Mar 2022
EPS came in at -$0.08 surpassing the estimated -$0.23 by +64.44%, while revenue for the quarter reached $300.00k , beating expectations by +20.00%.
Earnings released on 10 Nov 2021
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%, while revenue for the quarter reached $269.58k , missing expectations by -10.14%.
Earnings released on 11 Aug 2021
EPS came in at -$0.09 surpassing the estimated -$0.25 by +63.24%, while revenue for the quarter reached $326.01k , beating expectations by +8.67%.
FEMY Stock Performance
Access detailed FEMY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
